Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02733172 · ClinicalTrials.gov registry record

Profiling Vulvodynia Based on Neurobiological and Behavioral Endophenotypes

A clinical trial of Vulvodynia, sponsored by University of California, Los Angeles.

Completed
Registry status
168
Enrollment target
1
Study location

NCT02733172 is a study of Vulvodynia that has completed, run by University of California, Los Angeles. The registered enrollment target is 168 participants, above the 119-participant average among 9 other Vulvodynia trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02733172, a study of Vulvodynia, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
168 participants
Enrollment target
1
Study location

Study Summary

The investigators plan to extensively phenotype a large sample of Vulvodynia (VD) patients using functional and structural brain imaging together with genetic, physiological, and biological parameters.

Conditions Studied

Study Locations (1)

California

  • University of California, Los Angeles (UCLA) - Los Angeles

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2013-07
Est. Completion 2018-06-30

What the Registry Record Tells You About NCT02733172

The ClinicalTrials.gov registry entry for NCT02733172 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 119-participant average among 9 other Vulvodynia trials with a reported enrollment target (41% higher). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vulvodynia appearing as the primary indexed condition, and to 0 interventions.

NCT02733172 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02733172 about?

NCT02733172 is a clinical study titled "Profiling Vulvodynia Based on Neurobiological and Behavioral Endophenotypes". The investigators plan to extensively phenotype a large sample of Vulvodynia (VD) patients using functional and structural brain imaging together with genetic, physiological, and biological parameters.

What is the current status of trial NCT02733172?

This trial is currently completed. The enrollment target is 168 participants. The study started on 2013-07. Estimated completion is 2018-06-30.

What conditions does trial NCT02733172 study?

This clinical trial studies the following conditions: Vulvodynia.

Who is sponsoring clinical trial NCT02733172?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02733172 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vulvodynia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.